Patent: 9,808,438
✉ Email this page to a colleague
Summary for Patent: 9,808,438
Title: | Method for treating mucositis |
Abstract: | The invention provides a pharmaceutical composition for preventing or treating mucositis, for example oral mucositis (e.g., oral ulceration) and gastrointestinal mucositis, comprising a monoacetyldiacylglycerol compound, especially PLAG, and a method of preventing or treating mucositis using the same. |
Inventor(s): | Sohn; Ki-Young (Seoul, KR) |
Assignee: | Enzychem Lifesciences Corporation (Seoul, KR) |
Application Number: | 14/959,750 |
Patent Claims: | see list of patent claims |
Details for Patent 9,808,438
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Swedish Orphan Biovitrum Ab (publ) | KEPIVANCE | palifermin | For Injection | 125103 | 12/15/2004 | ⤷ Try a Trial | 2039-02-26 |
Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 11/18/2011 | ⤷ Try a Trial | 2039-02-26 |
Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 08/16/2018 | ⤷ Try a Trial | 2039-02-26 |
Seagen Inc. | ADCETRIS | brentuximab vedotin | For Injection | 125388 | 08/19/2011 | ⤷ Try a Trial | 2039-02-26 |
Sanofi-aventis U.s. Llc | ZALTRAP | ziv-aflibercept | Injection | 125418 | 08/03/2012 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |